Efficacy and Safety of LNP023 Compared With Rituximab in Subjects With Idiopathic Membranous Nephropathy
Clinical trial NCT04154787 · TERMINATED
Trial details
- NCT number
- NCT04154787
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-23
- Primary completion
- 2023-01-20
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.